Let's talk medical research

More than 80,000 people in the US will be diagnosed with bladder cancer this year. Treatment options have come a long way, and now include surgery, ...

We recently announced a collaboration with Ben’s Friends, a network of online communities for people impacted by rare disease, and MyRareData, an ...

With what we’re learning from the COVID-19 pandemic, can we create a permanent solution to keep the patient at the heart of clinical research? Last ...

Biliary tract cancer (BTC) is a rare form of cancer that develops in the bile duct system, which connects the liver, gallbladder, and small ...

An interview with Lindsey Wahlstrom-Edwards, Head of Partnerships at Antidote

In 2018, Antidote worked with SCORR Marketing and eight leading health organizations, including the Melanoma Research Alliance (MRA), to survey 4,000 ...

For people living with inflammatory bowel disease (IBD), the symptoms – diarrhea, bleeding ulcers, stomach pain, cramping, and weight loss – can be ...

A Q&A with Yvonne Taylor, Antidote’s senior clinical site operations manager Digital vendors work closely with clinical trial sites to ensure ...

Idiopathic pulmonary fibrosis (IPF) is a progressive disease that causes scarring of the lungs. Over time, the scarring worsens and it can become ...

In the midst of the COVID-19 pandemic, it seems like everything has gone digital, from scheduling video chat appointments with your doctor to Zoom ...